FHI is a research-based platform designed to help determine the readiness of countries to address global health challenges and build sustainable, fit-for-purpose national health systems. Using the real-life learning of experts in the field, and insights uncovered in research, the FHI provides actionable recommendations for the healthcare industry; particularly around the adoption and implementation of crucial digital tools that can deliver more affordable, integrated and sustainable care. A key finding of the FHI is that integrating connected care technology into health systems can accelerate countries along the path to value-based healthcare.
About Royal Philips
Ad Statistics
Times Displayed: 50295
Times Visited: 1434 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Royal Philips (NYSE :PHG , AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries.
SOURCE Royal Philips
Back to HCB News
